Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB26FWEYH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for STELARA 90 mg/ml syringes. This delivery order, issued on October 30, 2025, represents a single transaction under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement, with an ultimate completion date of November 21, 2025.
DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the Department of Defense's medical supply chain, authorized to distribute a comprehensive portfolio of branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities worldwide. The vendor's underlying prime vendor contract, awarded on November 13, 2025, carries a $499.999 billion ceiling value through December 31, 2036, positioning the company as a regional supplier within the broader $30.3 billion PPV-G GEN V acquisition strategy designed to modernize and consolidate pharmaceutical supply chain operations across the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FWEYH?
SPE2DB26FWEYH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FWEYH worth?
The government has obligated $16,250 on SPE2DB26FWEYH.
Is contract SPE2DB26FWEYH an order under another contract?
Yes. SPE2DB26FWEYH is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB26FWEYH competed?
The extent of competition for SPE2DB26FWEYH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award